M&A Deal Summary |
|
|---|---|
| Date | 2022-08-30 |
| Target | Bergstrom Nutrition |
| Sector | Consumer Products |
| Buyer(s) | Balchem |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Balchem develops, manufactures, and sells specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally. Balchem was founded in 1967 and is based in Montvale, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 7 |
| Sector (Consumer Products) | 1 of 1 |
| Type (Add-on Acquisition) | 7 of 7 |
| State (Washington) | 1 of 1 |
| Country (United States) | 5 of 5 |
| Year (2022) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-14 |
Kappa Bioscience
Oslo, Norway Kappa Bioscience is a science-based manufacturer of specialty vitamin K2 for the human nutrition industry. The company's discoveries include: The synthesis of pure, all-bioactive vitamin K2 MK-7, an essential vitamin needed to direct calcium around our bodies and keep hearts, bones, and lots of other things healthy. Today, that pioneering spirit is still as strong as ever. With patented processes, innovative technology, and renowned expertise, Kappa Bioscience AS produces K2VITAL and K2VITAL Delta; vitamin K2 with unmatched purity and stability, in a wider range of formulations than anyone else, to bring the best possible benefits of vitamin K2 to everyone. From vitamin K2 and turn-key solutions to research and marketing initiatives, to product launches and growth strategies, Kappa Bioscience AS believes in doing it right. That means developing products and services that set new standards of excellence, made with integrity, and through close collaboration. Kappa Bioscience was formed in 2006 and is based in Hamburg, Germany. |
Buy | - |
